Mairaj M Siddiquei

Mr. Mairaj M Siddiquei

Ophthalmology, King Saud University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid
Keen to expand and open for collaboration in DR

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
Mohammad OlaMohammad Ola
Mohammad Ola
MOHD NAWAZMOHD NAWAZ
MOHD NAWAZ
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei
SASaleh Al-Amro
Saleh Al-Amro
AEAhmed M. Abu El-Asrar
Ahmed M. Abu El-Asrar

1 February 2013 in Experimental Eye Research
Verified
Journal Article
Closed access
GMGHULAM MOHAMMAD
GHULAM MOHAMMAD
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei
AOAmira Othman
Amira Othman
Mohamed Al-ShabraweyMohamed Al-Shabrawey
Mohamed Al-Shabrawey
AEAhmed M. Abu El-Asrar
Ahmed M. Abu El-Asrar

29 September 2012 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
AEAhmed Abu El-Asrar
Ahmed Abu El-Asrar
MOHD NAWAZMOHD NAWAZ
MOHD NAWAZ
DKDustan Kangave
Dustan Kangave
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei
KGKarel Geboes
Karel Geboes
The aim of this study was to determine the levels of the angiogenic and fibrogenic factors osteopontin (OPN), high-mobility group box-1 (HMGB1), and connective tissue growth factor (CTGF) and the antiangiogenic and antifibrogenic pigment epithelium-derived factor (PEDF) in the vitreous fluid from patients with proliferative diabetic retinopathy (PDR), proliferative vitreoretinopathy (PVR), and rhegmatogenous retinal detachment with no PVR (RD). Vitreous samples from 48 PDR, 17 PVR and 30 RD patients were studied by enzyme-linked immunosorbent assay. OPN, HMGB1, CTGF, and PEDF levels were significantly higher in PDR patients than in RD patients (; 0.002; <0.001; <0.001, resp.). CTGF and PEDF levels were significantly higher in PVR patients than in RD patients (, resp.). Exploratory logistic regression analysis identified significant associations between PDR and high levels of HMGB1, CTGF and PEDF, between PDR with active neovascularization and high levels of CTGF and PEDF, and between PDR with traction retinal detachment and high levels of HMGB1. In patients with PDR, there were significant correlations between the levels of PEDF and the levels of OPN (), HMGB1 (), and CTGF (). In patients with PVR, there were significant correlations between the levels of OPN and the levels of HMGB1 () and PEDF (). Our findings suggest that OPN, HMGB1, and CTGF contribute to the pathogenesis of proliferative vitreoretinal disorders and that increased levels of PEDF may be a response to counterbalance the activity of angiogenic and fibrogenic factors in PDR and PVR.

10 March 2013 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
AEAhmed Abu El-Asrar
Ahmed Abu El-Asrar
MOHD NAWAZMOHD NAWAZ
MOHD NAWAZ
DKDustan Kangave
Dustan Kangave
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei
KGKarel Geboes
Karel Geboes
This study was conducted to determine levels of angiogenic and endothelial progenitor cell mobilizing (vasculogenic) factors in vitreous fluid from proliferative diabetic retinopathy (PDR) patients and correlate their levels with clinical disease activity. Vascular endothelial growth factor (VEGF), soluble vascular endothelial growth factor receptor-2 (sVEGFR-2), stem cell factor (SCF), soluble c-kit (s-kit), endothelial nitric oxide synthase (eNOS), and prostaglandin E2 (PGE2) levels were measured by ELISA in vitreous samples from 34 PDR and 15 nondiabetic patients. eNOS was not detected. VEGF, sVEGFR-2, SCF, and s-kit levels were significantly higher in PDR with active neovascularization compared with quiescent PDR and nondiabetic patients (; 0.007; 0.001; , resp.). In contrast, PGE2 levels were significantly higher in nondiabetic patients compared with PDR patients (). There were significant correlations between levels of sVEGFR-2 versus SCF (, ), sVEGFR-2 versus s-kit (, ), and SCF versus s-kit (, ). Our findings suggest that upregulation of VEGF, sVEGFR-2, SCF, and s-kit supports the contributions of angiogenesis and vasculogenesis in pathogenesis of PDR.

1 March 2012 in Journal of Ocular Biology, Diseases, and Informatics
Verified
Journal Article
Closed access
PDF file
GMGHULAM MOHAMMAD
GHULAM MOHAMMAD
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei

21 November 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GMGHULAM MOHAMMAD
GHULAM MOHAMMAD
Mairaj M SiddiqueiMairaj M Siddiquei
Mairaj M Siddiquei
AEAhmed Abu El-Asrar
Ahmed Abu El-Asrar
Retinal neuropathy is an early event in the development of diabetic retinopathy. One of the potential enzymes that are activated by oxidative stress in the diabetic retina is poly (ADP-ribose) polymerase (PARP). We investigated the effect of the PARP inhibitor 1,5-isoquinolinediol on the expression of the neurodegeneration mediators and markers in the retinas of diabetic rats. After two weeks of streptozotocin-induced diabetes, rats were treated with 1,5-isoquinolinediol (3 mg/kg/day). After 4 weeks of diabetes, the retinas were harvested and the levels of reactive oxygen species (ROS) were determined fluorometrically and the expressions of PARP, phosporylated-ERK1/2, BDNF, synaptophysin, glutamine synthetase (GS), and caspase-3 were determined by Western blot analysis. Retinal levels of ROS, PARP-1/2, phosphorylated ERK1/2, and cleaved caspase-3 were significantly increased, whereas the expressions of BDNF synaptophysin and GS were significantly decreased in the retinas of diabetic rats, compared to nondiabetic rats. Administration of 1,5-isoquinolinediol did not affect the metabolic status of the diabetic rats, but it significantly attenuated diabetes-induced upregulation of PARP, ROS, ERK1/2phosphorylation, and cleaved caspase-3 and downregulation of BDNF, synaptophysin, and GS. These findings suggest a beneficial effect of the PARP inhibitor in increasing neurotrophic support and ameliorating early retinal neuropathy induced by diabetes.